On September 17, 2026, Pulsenmore Ltd. announced the completion of MHRA registration for its Pulsenmore FC home ultrasound system, enabling marketing in the UK and Northern Ireland. This regulatory approval follows recent European MDR certification and allows patients to perform vaginal ultrasounds at home to monitor follicular development during IVF treatments. The move expands the company's platform into a significant fertility market where over 100,000 cycles were performed in 2024. Pulsenmore Ltd. is a healthcare technology company focused on transforming women’s healthcare through remote ultrasound and telemedicine solutions.
